Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$2.84 - $3.92 $532,173 - $734,549
187,385 Added 1864.9%
197,433 $768,000
Q4 2022

Feb 14, 2023

SELL
$2.48 - $5.93 $148,011 - $353,914
-59,682 Reduced 85.59%
10,048 $34,000
Q3 2022

Nov 14, 2022

SELL
$4.08 - $5.82 $12,705 - $18,123
-3,114 Reduced 4.27%
69,730 $381,000
Q2 2022

Aug 15, 2022

SELL
$4.15 - $8.37 $95,267 - $192,141
-22,956 Reduced 23.96%
72,844 $329,000
Q4 2021

Feb 11, 2022

BUY
$5.21 - $8.61 $2,084 - $3,444
400 Added 0.42%
95,800 $616,000
Q1 2021

May 17, 2021

SELL
$9.85 - $17.69 $45,310 - $81,374
-4,600 Reduced 4.6%
95,400 $1 Million
Q4 2020

Feb 03, 2021

SELL
$14.15 - $17.19 $491,005 - $596,493
-34,700 Reduced 25.76%
100,000 $1.55 Million
Q3 2020

Nov 16, 2020

BUY
$14.14 - $19.71 $507,626 - $707,589
35,900 Added 36.34%
134,700 $1.97 Million
Q2 2020

Aug 12, 2020

BUY
$16.6 - $25.25 $114,540 - $174,225
6,900 Added 7.51%
98,800 $1.87 Million
Q1 2020

May 06, 2020

BUY
$14.38 - $27.72 $76,214 - $146,916
5,300 Added 6.12%
91,900 $1.77 Million
Q3 2019

Nov 12, 2019

BUY
$5.66 - $11.85 $114,332 - $239,370
20,200 Added 30.42%
86,600 $833,000
Q2 2019

Aug 14, 2019

BUY
$4.32 - $6.43 $6,480 - $9,645
1,500 Added 2.31%
66,400 $398,000
Q1 2019

May 13, 2019

BUY
$4.12 - $10.25 $61,388 - $152,725
14,900 Added 29.8%
64,900 $379,000
Q4 2018

Feb 11, 2019

BUY
$8.2 - $16.95 $4,920 - $10,170
600 Added 1.21%
50,000 $468,000
Q2 2018

Aug 03, 2018

BUY
$12.0 - $19.88 $280,800 - $465,192
23,400 Added 90.0%
49,400 $839,000
Q3 2017

Nov 01, 2017

BUY
$8.15 - $11.16 $211,900 - $290,160
26,000
26,000 $285,000

Others Institutions Holding KPTI

About Karyopharm Therapeutics Inc.


  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $55.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.